14 December 2011
Evolva obtains patent coverage in Russia on EV-077 for use in complications of diabetes
08 December 2011
Swiss-based Evolva Holding SA receives second milestone payment from Roche
15 November 2011
Evolva will profit from the EU approval of the use of Stevia in food and beverages
07 November 2011
Evolva receives clearance to progress its pharmaceutical compound EV-077 into Phase IIa
15 August 2011
Swiss-based Evolva secures financing of up to CHF 30 million
03 August 2011
Evolva strengthened by Renowned Synthetic Biology and Metabolic Engineering Experts
02 May 2011
Evolva appoints Norbert Bender as Chief Medical Officer
26 April 2011
Evolva proposes leading biotech and food ingredient executives to join its Board
05 April 2011
Evolva to Acquire Abunda Nutrition
28 March 2011
FDA clears Evolva’s IND for EV-077 in influenza
22 March 2011
Evolva to enter the Swiss SPI stock index
07 March 2011
BASF and Evolva enter into a collaboration to develop compounds applied to protect crops
14 February 2011
Evolva announces pre-clinical efficacy data with EV-077 in influenza
13 January 2011
Evolva enters into collaboration with International Flavors & Fragrances Inc.
Evolva obtains patent coverage in Russia on EV-077 for use in complications of diabetes
08 December 2011
Swiss-based Evolva Holding SA receives second milestone payment from Roche
15 November 2011
Evolva will profit from the EU approval of the use of Stevia in food and beverages
07 November 2011
Evolva receives clearance to progress its pharmaceutical compound EV-077 into Phase IIa
15 August 2011
Swiss-based Evolva secures financing of up to CHF 30 million
03 August 2011
Evolva strengthened by Renowned Synthetic Biology and Metabolic Engineering Experts
02 May 2011
Evolva appoints Norbert Bender as Chief Medical Officer
26 April 2011
Evolva proposes leading biotech and food ingredient executives to join its Board
05 April 2011
Evolva to Acquire Abunda Nutrition
28 March 2011
FDA clears Evolva’s IND for EV-077 in influenza
22 March 2011
Evolva to enter the Swiss SPI stock index
07 March 2011
BASF and Evolva enter into a collaboration to develop compounds applied to protect crops
14 February 2011
Evolva announces pre-clinical efficacy data with EV-077 in influenza
13 January 2011
Evolva enters into collaboration with International Flavors & Fragrances Inc.
